A single center, double-blind, randomized trial to evaluate the effects of aspirin 325 mg + clopidogrel 75 mg v. aspirin 325 mg + placebo on plasma concentration of C-reactive protein: the CATER trial protocol

Trial Profile

A single center, double-blind, randomized trial to evaluate the effects of aspirin 325 mg + clopidogrel 75 mg v. aspirin 325 mg + placebo on plasma concentration of C-reactive protein: the CATER trial protocol

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 11 Dec 2006

At a glance

  • Drugs Clopidogrel (Primary)
  • Indications Coronary artery disease; Embolism and thrombosis
  • Focus Pharmacodynamics
  • Acronyms CATER
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 11 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top